1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2020 TO 2023]
Date Issued:  2021

Results 1-20 of 23 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
13-Sep-2021A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)Chen, Yunxin ; Gopalakrishnan, Sathish Kumar; Ooi, Melissa ; Sultana, Rehena ; Lim, Li Hui; Grigoropoulos, Nicholas ; Ong, Shin Yeu ; Xu, Mingge; Chng, Wee Joo ; Goh, Yeow Tee ; Nagarajan, Chandramouli
21-Jun-2021A unique rhinologic manifestation of multiple myelomaSeah, Jun Jie; Chng, Wee Joo ; Thong, Mark Kim Thye
323-Feb-2021Application of Advanced Mass Spectrometry-Based Proteomics to Study Hypoxia Driven Cancer ProgressionVinaiphat, Arada; Low, Jee Keem; Yeoh, Kheng Wei ; Chng, Wee Joo ; Sze, Siu Kwan
429-Apr-2021CAR T-cell therapy in multiple myeloma: more room for improvementTeoh, Phaik Ju ; Chng, Wee Joo 
516-Aug-2021Chromatin interaction neural network (ChINN): a machine learning-based method for predicting chromatin interactions from DNA sequencesCao, Fan ; Zhang, Yu; Cai, Yichao; Animesh, Sambhavi; Zhang, Ying; Akincilar, Semih Can; Loh, Yan Ping; Li, Xinya; Chng, Wee Joo ; Tergaonkar, Vinay ; Kwoh, Chee Keong; Fullwood, Melissa J 
618-Feb-2021Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myelomaXiong, Sinan; Chng, Wee-Joo ; Zhou, Jianbiao 
71-Mar-2021Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysisChong, Lip Leong; Soon, Yu Yang ; Soekojo, Cinnie Yentia; Ooi, Melissa ; Chng, Wee Joo ; de Mel, Sanjay
816-Oct-2021DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypesKizhakeyil, Atish; Zaini, Nurmahirah Binte Mohammed; Poh, Zhi Sheng; Wong, Brandon Han Siang; Loh, Xinpeng; Ng, Aik Seng; Low, Zun Siong; Prasannan, Praseetha; Gong, Chun; Tan, Michelle Guet Khim; Nagarajan, Chandramouli; Huang, Dachuan; Lu, Pang Wan; Lim, Jing Quan; Barrans, Sharon; Ong, Choon Kiat; Lim, Soon Thye; Chng, Wee Joo ; Follows, George; Hodson, Daniel J; Du, Ming Qing; Goh, Yeow Tee; Tan, Suat Hoon; Grigoropoulos, Nicholas Francis; Verma, Navin Kumar
91-Jan-2021Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphomaMustafa, Nurulhuda ; Nee, Adina Huey Fang ; Chooi, Jing Yuan ; Toh, Sabrina Hui Min ; Chung, Tae-Hoon ; Selvarajan, Viknesvaran ; Fan, Shuangyi ; Ng, Siok Bian ; Poon, Michelle ; Chan, Esther ; Lee, Joanne; Chee, Yen Lin ; Jeyasekharan, Anand D ; Zhou, Longen; Yang, Jennifer; Chng, Wee Joo 
101-Sep-2021Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsLee, Wen-Hsin Sandy; Ye, Zhiyong; Cheung, Alice MS; Goh, YP Sharon; Oh, Hsueh Ling Janice; Rajarethinam, Ravisankar; Yeo, Siok Ping; Soh, Mun Kuen; Li Chan, Esther Hian; Tan, Lip Kun; Tan, Soo-Yong ; Chuah, Charles ; Chng, Wee Joo ; Connolly, John E; Wang, Cheng-I
1112-Aug-2021High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaOng, Shin Yeu ; de Mel, Sanjay; Grigoropoulos, Nicholas Francis ; Chen, Yunxin ; Tan, Yan Chin; Tan, Melinda Si Yun ; Ng, Lawrence Cheng Kiat ; Lee, Yuh Shan; Phipps, Colin; Goh, Yeow Tee ; Yong, Kar Ying; Liu, Xin; Chng, Wee Joo ; Lim, Soon Thye ; Nagarajan, Chandramouli 
1219-Jul-2021Identification of differential RNA modifications from nanopore direct RNA sequencing with xPorePratanwanich, Ploy N; Yao, Fei; Chen, Ying; Koh, Casslynn WQ; Wan, Yuk Kei; Hendra, Christopher; Poon, Polly; Goh, Yeek Teck; Yap, Phoebe ML; Chooi, Jing Yuan; Chng, Wee Joo ; Ng, Sarah B; Thiery, Alexandre ; Goh, WS Sho; Goke, Jonathan
131-Oct-2021Janus Kinase Signaling: Oncogenic Criminal of Lymphoid CancersLi, Boheng; Wan, Qin; Li, Zhubo; Chng, Wee-Joo 
141-Dec-2021Lipid profiles and outcomes of patients with prior cancer and subsequent myocardial infarction or strokeKoo, CY ; Zheng, H ; Tan, LL ; Foo, LL; Seet, R ; Chong, JH ; Hausenloy, DJ ; Chng, WJ ; Richards, AM ; Lee, CH ; Chan, MY 
151-Feb-2021Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportMurray, David L; Puig, Noemi; Kristinsson, Sigurdur; Usmani, Saad Z; Dispenzieri, Angela; Bianchi, Giada; Kumar, Shaji; Chng, Wee Joo ; Hajek, Roman; Paiva, Bruno; Waage, Anders; Rajkumar, S Vincent; Durie, Brian
1612-Feb-2021Myeloma-specific superenhancers affect genes of biological and clinical relevance in myelomaJia, Yunlu; Zhou, Jianbiao; Tan, Tze King ; Chung, Tae-Hoon; Wong, Regina Wan Ju ; Chooi, Jing-Yuan ; Lim, Julia Sze Lynn ; Sanda, Takaomi ; Ooi, Melissa; De Mel, Sanjay; Soekojo, Cinnie; Chen, Yongxia; Zhang, Enfan; Cai, Zhen; Shen, Peng; Ruan, Jian; Chng, Wee-Joo 
172-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
1826-Aug-2021Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trialsChen, Yan-Ting; Valent, Erik T; van Beers, Erik H; Kuiper, Rowan; Oliva, Stefania; Haferlach, Torsten; Chng, Wee-Joo ; van Vliet, Martin H; Sonneveld, Pieter; Larocca, Alessandra
1928-Jan-2021RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemiaKoschut, David; Ray, Debleena; Li, Zhenhua ; Giarin, Emanuela; Groet, Jurgen; Alic, Ivan; Kham, Shirley Kow-Yin; Chng, Wee Joo ; Ariffin, Hany; Weinstock, David M; Yeoh, Allen Eng-Juh; Basso, Giuseppe; Nizetic, Dean
201-May-2021SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple MyelomaChong, Phyllis SY ; Chooi, Jing Yuan; Lim, Julia SL ; Toh, Sabrina Hui Min ; Tan, Tuan Zea ; Chng, Wee-Joo